跳至主要内容
临床试验/NCT00757315
NCT00757315Unknown不适用

Prospective, Controlled Study of the Efficacy of NdYag for Acne Keloidalis Nuchae

Henry Ford Health System1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2008年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
20
试验地点
1
主要终点
reduction in severity of AKN as measured by a novel AKN severity scoring system which incorporates number of lesions, size of lesions, type of lesions and associated inflammation.

研究概览

简要总结

Acne Keloidalis Nuchae (AKN) is a long standing hair follicle disease with bumps and scars on the skin of the back of the head and neck. The purpose of this new study is to determine how well a hair removal laser (NdYag Laser) works in treating AKN.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • For inclusion, the subject must:
  • Be at least 18 years old
  • Be otherwise healthy
  • Have a diagnosis of AKN with at least 10 papules/pustules and/or a non-keloidal plaque > 7 cm2 in area.

排除标准

  • Subject must not:
  • Have AKN with a keloidal plaque >3 cm in length
  • Be using any other medications or undergoing any other procedures for the treatment of AKN
  • Have used any topical medications or undergone any procedures for the treatments of AKN within two weeks of study enrollment
  • Have used any oral medications for AKN within 4 weeks of study enrollment:
  • Have serious, uncontrolled medical conditions
  • Be pregnant at any time during the study.

研究组 & 干预措施

1

Experimental

干预措施: NdYag Laser(hair removal laser) plus topical corticosteroid (Device)

2

Active Comparator

干预措施: Topical corticosteroid alone (Drug)

结局指标

主要结局

reduction in severity of AKN as measured by a novel AKN severity scoring system which incorporates number of lesions, size of lesions, type of lesions and associated inflammation.

时间窗: 6 months

次要结局

  • Treatment tolerability as measured by 0 to 10 pain scale(6 months)
  • treatment safety(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Iltefat Hamzavi

Dermatologist

Henry Ford Health System

研究点 (1)

Loading locations...

相似试验